Self-Reported Dyspnea Is Associated with Reduced Health-Related Quality of Life in Quaternary Hospital Workers 1 Year Post Mild COVID-19 Infection

Abstract

Background/Objectives: The COVID-19 pandemic had significant implications for healthcare workers (HWs), especially those that work in hospitals. This study evaluated health related quality of life (HRQOL) and its relationship with dyspnea approximately one year after COVID-19 infection in HWs. Methods: HWs with previous COVID-19 infections were interviewed, and the EuroQol five-dimensional three-level questionnaire (EQ-5D-3L) with a visual analog scale (VAS) was used to evaluate HRQOL. Self-reported clinical and sociodemographic data were also obtained. Data were stratified by the presence of self-reported dyspnea in the moment of the study interview. The association between self-reported dyspnea and HRQOL was evaluated by regression models, either unadjusted or adjusted for potential confounders (for age and sex, marital status, work category, number of comorbidities, and number of days between diagnosis and evaluation). Results: A total of 109 HWs were interviewed; the median number of days post COVID-19 diagnosis for this group was 400 (IIQ 25–75% 321–428). The majority were women (67.9%); the median age was 44 (IIQ 25–75% 38–52) years. Overall, the median EQ-5D-3L score was 0.79 (IIQ 25–75% 0.74–0.85), and the median VAS score was 80 (IIQ 25–75% 70–90). Self-reported dyspnea was indicated by 22 individuals (20.2%). Self-reported dyspnea was associated with lower EQ-5D-3L and VAS scores, both in adjusted and non-adjusted models. In addition, self-reported dyspnea was associated with more problems in carrying out usual activities in both the non-adjusted and adjusted models (p < 0.01). Conclusions: Our results underscore the long-term implications of COVID-19, based on persistent perceptions of self-reported dyspnea and its relationship with HRQOL in HWs. Future studies, with extended follow-up and the employment of cardiopulmonary and mental health testing, may help to elucidate the nature and extent of COVID-19 sequelae.